BioSpace News Archive

Silverback Therapeutics™ (“Silverback”) today announced that Laura Shawver, Ph.D., was appointed president, chief executive officer and director of Silverback Therapeutics to lead the next phase of growth utilizing ImmunoTAC™ therapeutics that are administered systemically, tissue-directed, and locally active with a pipeline of programs in oncology, fibrosis and virology. Dr. Shawver brings more than 25 years of demonstrated

Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and leader in predictive target discovery, announced today that The European Patent Office (EPO) has granted the Company a new patent for the composition of COM701 or backup antibodies for the treatment of cancer. EPO Patent No. 3295951 , titled “Anti-P

Teladoc Health, Inc., the global leader in virtual care, announced that it will release first-quarter 2020 results on Wednesday, April 29th, 2020, after the market closes.

New Laboratory Tests Conducted by Utah-Based Institute for Antiviral Research Confirm SaNOtize’s Nitric Oxide Releasing Solution (NORS TM ) is Over 99.9% Effective Against SARS-CoV-2, the Virus that Causes COVID-19 VANCOUVER , April 22, 2020 /CNW/ - SaNOtize Research and Development Corporation (“SaNOtize” or “the company”) today announced that it has be

Artificial Intelligence (AI) and computational biophysics will be deployed to rapidly develop drugs for COVID-19 and other viral infections based on Mannin Research’s Tie2 platform in new joint venture with Cyclica

HBI Solutions, a leader in predictive analytics for healthcare announces it has recently passed certification on a partial list of 2020 HEDIS® measures.

Invacare Corporation (NYSE:IVC) (“Invacare” or the “company”) announces that it will release its financial results for the first quarter ended March 31, 2020, after the market closes on Wednesday, May 6, 2020. The company will provide a live conference call and webcast to discuss these financial results on Thursday, May 7, 2020 at 8:30 AM ET. Investors and other interested par

Vivera Pharmaceuticals, Inc., a California based pharmaceutical company has started nationwide delivery of its point of care, serological antibody rapid Covid-19 test kits.

Nanobeak Biotech Inc., a pioneer in mobile, non-invasive disease detection at the earliest stages, announced that Jeremy Barbera, Board member and Chief Science Officer, has been relieved of his duties and is no longer associated with the company, as of April 3, 2020.

The Health Care business of LexisNexis® Risk Solutions has launched a free COVID-19 Data Resource Center to provide county-level insights on at-risk populations and potential care capacity gaps to support the U.S. healthcare industry’s response to the COVID-19 pandemic